Celebrex News Archive
Yet Another Study Confirms That Higher Doses of Celebrex Are Associated with Increased Risk of Heart Attack and Stroke
-InjuryBoard.com
04/14/2008- On March 31, 2008, a study funded by the National Cancer Institute, was published in the medical journal Circulation and analyzed data from six separate studies involving nearly 8,000 patients concerning the safety of the drug Celebrex. Data showed that patients who took two 400 mg doses of Celebrex daily had a three times (or 300%) higher risk of suffering heart attacks, strokes, heart failure, blood clots, and cardiovascular death. More>>>
Nephrologist Blamed Celebrex for Kidney Problems and Hypertension
-LawyersandSettlements.com
03/30/2008-
Raleigh, NC: Bess W. was referred to a nephrologist to evaluate her kidney function. "All this time she was still on 200mg of Celebrex daily," says her husband Reid. "The specialist reported to her primary care physician that she had progressive renal insufficiency due to analgesic neuropathy from many years of non-steroidal and COX-2 use. He also said that her accelerated hypertension and edema are probably related to her worsening renal disease and
Celebrex.
More>>>
Pfizer wants Tillery to cough up plaintiffs' Celebrex and Bextra Rx bills
-stclairrecord.com
02/27/2008 - Drug maker Pfizer has delivered 36 million pages of facts about painkillers Celebrex and Bextra to class action attorney Stephen Tillery, but he won't tell Pfizer who prescribed the pills for his clients or who paid for the pills. More>>>
Vioxx Heart Risks Began Earlier than Thought
-NPR
05/18/2006 - New data obtained by NPR show that patients who took Vioxx even for short periods were at higher risk of heart problems and strokes. An estimated 20 million Americans took the painkiller before Merck & Co. stopped selling it in 2004. More>>>
Medical Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers
-New York Times
02/16/2005 - A panel of federal drug advisers who gathered here on Wednesday to judge the safety of the heavy-selling pain pills Celebrex, Bextra and Vioxx were tough, sometimes even caustic, in their remarks about the drugs, suggesting that the panel may take a hard line on their uses. More>>>
HMO Bans Bextra Until Safety is Proven
-AP
01/31/2005 - Kaiser Permanente, the nation's largest not-for-profit managed-care provider, has stopped prescribing Bextra until tests show whether the painkiller is safe.More>>>
US group says Pfizer hid Celebrex heart-link study
-Chicago Reuters
01/31/2005 - A U.S. consumer group on Monday accused Pfizer Inc. of burying a study suggesting its painkiller Celebrex boosts the risk of heart attack and stroke, the group's latest salvo in a bid to ban all drugs in theclass.More>>>
Scientists Give More Evidence of Vioxx Heart Risks
-Reuters
01/25/2005 - Vioxx, the painkiller recalled last September because of safety concerns, may have caused up to 140,000 cases of serious heart disease in the United States, researchers said on Tuesday. More>>>
Study Suggests How COX Drugs Cause Heart Disease
-Reuters
11/18/2004 - Painkillers suspected of causing fatal heart disease may act by starting the process of hardening the arteries, researchers proposed on Thursday.More>>>
Celebrex News - Doctors Don’t Agree on Bextra Risk
-Newsweek
11/12/2004 - Less than six weeks after Vioxx was pulled from pharmacy shelves because of evidence it increased a patient's risk of heart attack or stroke, some researchers are raising similar concerns about Bextra, another popular arthritis-pain reliever in the same class of drugs as Vioxx.More>>>
A New Trial of Celebrex, and Questions on Its Timing
-New York Times
10/19/2004 - Less than three weeks after Merck withdrew its arthritis painkiller Vioxx from the market because it increased the risk of heart attacks, Pfizer announced plans yesterday to test if its best-selling painkiller Celebrex, which is in the same class of drugs as Vioxx, can do the opposite - help prevent heart attacks. More>>>
